Maxamine histamine dihydrochloride: Phase III

In MAXM's 305-patient U.S. Phase III trial, the combination of Maxamine plus IL-2 met one of two primary end points of a significant increase in survival duration compared

Read the full 284 word article

How to gain access

Continue reading with a
two-week free trial.